SCHEMBL628951

SCHEMBL628951

CCCCN(C(C)=O)C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
ADH1A P07327 2/20 0.42
ADH1C P00326 1/20 0.39
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
PTBP1 P26599 1/20 0.39
HSD11B1 P28845 1/20 0.38
PYGL P06737 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NAAA Q02083 2/20 0.38
PIK3CD O00329 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9632611 0.93 THRA (0.43) ADH1AADH1CTHRATHRBNAAA
SCHEMBL9632418 0.93 THRA (0.43) ADH1AADH1CTHRATHRBNAAA
SCHEMBL4281691 0.89 ADH1A (0.48) L3MBTL1ADH1AADH1CALDH1A1LMNA
SCHEMBL6627705 0.88 ADH1A (0.37) L3MBTL1ADH1AADH1CHSD11B1
SCHEMBL9462350 0.86 ADH1A (0.47) L3MBTL1ADH1AADH1CALDH1A1LMNA
SCHEMBL5510945 0.85 L3MBTL1 (0.42) L3MBTL1ADH1AADH1CTHRATHRB
SCHEMBL13911314 0.84 ADH1A (0.44) L3MBTL1ADH1AADH1CALDH1A1LMNA
SCHEMBL9071877 0.84 L3MBTL1 (0.41) L3MBTL1ADH1AADH1CTHRATHRB
SCHEMBL9906109 0.83 L3MBTL1 (0.38) L3MBTL1ADH1AADH1CTHRATHRB
SCHEMBL19570761 0.82 L3MBTL1 (0.40) L3MBTL1ADH1AADH1CTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4234348-A None JP disclosed
EP-0986384-B1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2012-02-22 EP disclosed
US-6310095-B1 INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE UNIVERSITY OF PITTSBURGH 2001-10-30 US disclosed
EP-0468303-B1 Method of recovering carboxylic acids from their aqueous solutions BASF AG (DE) 1994-09-28 EP disclosed
US-5189216-A Isolation of a carboxylic acid from an aqueous solution thereof BASF AKTIENGESELLSCHAFT (DE) 1993-02-23 US disclosed
JP-H04234348-A METHOD FOR ISOLATING CARBOXYLIC ACID BASF AG 1992-08-24 JP disclosed
EP-0468303-A1 Method of recovering carboxylic acids from their aqueous solutions BASF Aktiengesellschaft (DE) 1992-01-29 EP disclosed
US-4217460-A Isolation of formic acid from its aqueous solutions BASF AKTIENGESELLSCHAFT (DE) 1980-08-12 US disclosed